Media & Rewards

Defymed and GlioCure initiate a collaboration in the field of solid tumors without therapeutic options

April 2022

Defymed receives approval to start its pilot clinical study with ExOlin®

January 2022

A new fund raising round for Defymed, to allow the entry into clinical phase of ExOlin® device

May 2020

Company rewards

Winner of the French Research Ministry contest for Innovative companies – in the category « Emergence» (2010)
Winner of the French Research Ministry contest for Innovative companies – in the category « Creation-development» (2011)
First prize winner of the “Tremplin Entreprise” contest of the French Senate in the category “Life Sciences” (2011)
Laureate of the “Universal Biotech” contest (2011)
Winner of the “Fond’Action Alsace” price in the category “Talent of the future”
“Innovative companies” label obtained of the French Bioclusters (2012)

Winner of the Fast 50 Deloitte-In Extenso prize (2014)
First laureate of the « Inventer demain» Award (2015)
Special award from INPI and gold medal with the jury mention at the 44th international inventions tradeshow in Geneva (2016)
Winner of the Medstartup- GalienAwards 2016 – Category ” Best Innovative trial design leading to quicker and better therapeutic outcome” (2016)
Winner of the INPI award (2017)
Winner of the Audience Award Price at the Start-up Slam of MedFIT2018 (2018)
Winner of the First Innovation prize (2018)
Winner of the First price in Health category at the “10000 Startups contest” (2019)
Séverine SIGRIST selected by La Tribune to join the French Women’s Leadership Team (2022)